Charles Aubrey LeMaistre, M.D.
1924-2017
Charles Aubrey “Mickey” LeMaistre, M.D., beloved physician, father, trusted friend and husband, passed away in Houston on January 28, 2017, less than two weeks before his 93rd birthday. Mickey was the epitome of a man who cared for others and practiced great discipline in his life.
Mickey LeMaistre’s career began at age 10, as a deckhand spotting fish for tourists in Hogtown...
Adding two blood-borne proteins associated with cancer cell migration increases the predictive ability of the current biomarker for pancreatic...
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an...
Next-generation cyclin dependent kinase 2/9 (CDK2/9) inhibitors offer a novel way to treat lung cancer with minimal toxic side effects on normal cells, according to a laboratory study by researchers at The University of Texas MD Anderson Cancer Center. The examined inhibitors were effective in stopping growth of lung cancer cells through induced anaphase catastrophe, a cellular pathway discovered at MD Anderson.
One of these highly...
Melanoma patients’ response to a major form of immunotherapy is associated with the diversity and makeup of trillions of potential allies...
For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma (LGSC), hormone maintenance...
The University of Texas MD Anderson Cancer Center this week was awarded $19.5 million from the Cancer Prevention and Research Institute of...
Women with early-stage breast cancer who had an intermediate risk recurrence score (RS) from a 21-gene expression assay had similar outcomes...
Recognizing a critical need to address disparities in cancer care, The University of Texas MD Anderson Cancer Center has been designated as...
Researchers have identified a gatekeeper protein that prevents pancreatic cancer cells from transitioning into a particularly aggressive cell...
Breast cancer patients with dense breast tissue have almost a two-fold increased risk of developing disease in the contralateral breast, according...
The University of Texas MD Anderson Cancer Center returns to Southern California this month with its Making Cancer History® Seminar, 3:30-...
A new method has been found for identifying therapeutic targets in cancers lacking specific key tumor suppressor genes. The process, which...
In honor of World Cancer Day on Feb. 4, The University of Texas MD Anderson Cancer Center calls for health care providers, organizations,...
The University of Texas MD Anderson Cancer Center today announced the appointment of Stephen Hahn, M.D., to the senior leadership role of...